Katherine Levy
Apr 14, 2011

Novartis to review US$600m global media business

GLOBAL - Novartis, the pharmaceutical giant, is gearing up to launch a review of its estimated US$600 million global media business.

Novatris currently works with incumbent MEC
Novatris currently works with incumbent MEC

WPP's MEC is the incumbent on the global business.

In 2008 Novartis consolidated its US media planning and buying into MEC after moving its business from sibling agency Mindshare in a global realignment.

Novartis, which is headquartered in Basel, Switzerland, has three other businesses called Pharmaceuticals, Vaccines and Diagnostics, and Sandoz Generics, a global supplier of generic medicines that are produced after a popular medicine's patent has expired.

This article was first published on campaignlive.co.uk.

Source:
Campaign Asia

Related Articles

Just Published

22 hours ago

AI, copyright, and creativity: The fine line ...

With tech giants lobbying for AI training on copyrighted material and artists filing lawsuits to protect their work, adland faces the challenge of integrating AI while respecting copyright, originality, and the livelihoods of creators.

22 hours ago

Women to Watch 2024: Vivian Liu, DeVries Global

A PR veteran, Liu empowers the next generation in Taiwan by promoting fairness, authenticity, and industry excellence.

23 hours ago

A new campaign gives dignity to Vietnam's unsung heroes

This Labour Day, a powerful tribute by creative agency The Friday urges us to see the workers we pass by without a second thought. But does recognition go far enough?

1 day ago

Amazon unveils first brand overhaul in 25 years, ...

The subtle design refresh spans over 50 sub-brands across categories like pharmacy, groceries, and on-demand streaming under a single brand umbrella.